Malignant ascites. Clinical and experimental observations.
about
Management of drainage for malignant ascites in gynaecological cancerThe trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trialSurgical technology and pharmacology of hyperthermic perioperative chemotherapyEfficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites.Palliative treatment of malignant ascites: profile of catumaxomab.Safety and efficacy of the PleurX catheter for the treatment of malignant ascites.Diagnostic investigations in cancer pain.Peritoneovenous shunting for nongynecologic malignant ascites.Palliative venting gastrostomy in patients with malignant bowel obstruction and ascites.How valuable is ascitic cytology in the detection and management of malignancy?Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer.Management of ascites due to gastrointestinal malignancy.Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures.Management of non-ovarian cancer malignant ascites through indwelling catheter drainage.Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone.Development and validation of the self-completed ascites impact measure to understand patient motivation for requesting a paracentesis.Synergistic effects of Endostar combined with β-elemene on malignant ascites in a mouse model.Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab.Outpatient Intraperitoneal Catumaxomab Therapy for Malignant Ascites Related to Advanced Gynecologic Neoplasms.Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites.Biomarkers of malignant ascites-a myth or reality.Therapeutic effects of Euphorbia Pekinensis and Glycyrrhiza glabra on Hepatocellular Carcinoma Ascites Partially Via Regulating the Frk-Arhgdib-Inpp5d-Avpr2-Aqp4 Signal Axis.Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims, and results: a systematic review of the literature.Body fluid analysis: clinical utility and applicability of published studies to guide interpretation of today's laboratory testing in serous fluids.Ascites in Ovarian Carcinoma - Reliability and Limitations of Cytological Analysis.Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapyA Novel Combination of C-Reactive Protein and Vascular Endothelial Growth Factor in Differential Diagnosis of Ascites.Matrix protein of vesicular stomatitis virus: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation.Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites.Anti-tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model.Preoperative hyponatremia in women with ovarian cancer: An additional cause for concern?The clinical significance of vascular endothelial growth factor in malignant ascites.New strategies for the management of malignant ascites.Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.Pelvic tuberculosis, echinococcosis, and actinomycosis: great imitators of ovarian cancer.Peritoneal lymphomatosis: a rare presentation of follicular lymphoma mimicking peritoneal carcinomatosis.Treatment of malignant ascites in patients with advanced cancer: peritoneovenous shunt versus paracentesis.Symptomatic Fluid Drainage: Tunneled Peritoneal and Pleural Catheters.Loss of PRP4K drives anoikis resistance in part by dysregulation of epidermal growth factor receptor endosomal trafficking.
P2860
Q24240934-6DB3864E-2E14-4DEB-A927-3B9D67B53DD6Q24629295-844FF9FA-CF9A-43AF-A891-C6CAF48FC9DFQ26768405-0C90205E-3465-4B35-BE4C-DDE17E04F3B8Q33875078-BB127010-C963-453D-8C6F-409ED25FCEB1Q33892606-AE0D247E-6735-447A-9A65-C42414EB1543Q33988120-2167F204-419C-4F80-ADD5-3793B80800C1Q34063265-C7C04E6E-9D82-4E43-B07E-21914973D9B1Q34205749-74012120-9BE0-482F-B9C6-B9A47406FC9DQ34672581-8CC30D14-2ECC-4522-B41F-2CD2AEFADEB5Q35143498-BC026388-714A-4C4E-A69B-BDE6F6E4DDA0Q35750271-B1613C9C-E9FB-4A6D-812E-A63038472486Q35789515-04689097-5BC8-4016-ABB6-7C6C90A36E0CQ35957129-D510DC85-BEA3-4DBB-AD8B-B2CFE4C0136DQ35996680-C6DF60BB-D9CC-4A4E-AC7B-3423BA4B6E18Q36112029-9976101B-6B36-41D3-95BA-D8B19ABB3333Q36160677-DC2DE304-8A43-422D-AF85-F3278BDEE430Q36285646-B96563A1-1F7D-4F5D-A3E1-D763B47BD00BQ36358324-6843468E-C149-47E0-9C5D-328585A466C7Q36413103-31F1B1AE-FD96-45DA-93C9-7DF2B301945AQ36478769-0C4A7D61-7509-4634-B657-0C49F2603BC0Q36639217-6EB7E796-9043-424D-A3F3-91872312FD85Q37037475-59C01CF5-8E1F-4916-9A96-E9FA03F72374Q37626077-8B580F18-767E-4B41-850D-C007ABD020C3Q38004840-B6D89128-BC40-435A-B4D5-96BB2CA5BAB5Q38155233-37605788-0CBC-4B4F-A2EB-8F8598BEC007Q38598954-568415F4-1E9D-49CD-8BFD-C2CFA72534B6Q38767385-13FD2C98-C90B-42A8-B09A-FCCA531C3D6AQ38855207-9FA86315-296E-45FE-8B1A-CB39AFDF5AAAQ39187132-8ADDBAD8-164E-4B39-9C2B-F84867D40828Q39200946-B08D4F99-8C89-4C8C-AF8A-FE723AF27E74Q40024233-075A616D-8558-419E-A424-76EA4C46B25AQ40387712-56FDC084-F68B-463A-862B-002F6964DE00Q40436743-34A3B981-FB43-4221-9094-7103C0BB6572Q40939018-C40B4142-895C-4F59-8FFF-987AAA486B65Q41552639-C2E6100A-29C1-4286-A2A0-25F28BB08CFBQ42229363-867A5C12-B4F9-4202-8626-4DEE9559CD9CQ43158122-5B8BE85C-95C4-433B-B4EA-67B637F82A22Q44230207-15432F6F-46C7-495E-916E-F0ABE6AB589CQ47678586-2FB537E0-68FE-42D3-A684-CE20BFB1B7CCQ48095106-1840A55C-53D9-40F2-B36E-CF91F27D8BDA
P2860
Malignant ascites. Clinical and experimental observations.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Malignant ascites. Clinical and experimental observations.
@en
type
label
Malignant ascites. Clinical and experimental observations.
@en
prefLabel
Malignant ascites. Clinical and experimental observations.
@en
P2093
P1433
P1476
Malignant ascites. Clinical and experimental observations.
@en
P2093
Galloway RH
Garrison RN
P304
P356
10.1097/00000658-198606000-00009
P407
P577
1986-06-01T00:00:00Z